Concord Biotech to host analyst meet on Sep 23 in Ahmedabad

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Concord Biotech to host group analyst meet on September 23, 2026
  • Session scheduled for 12:30 pm in Ahmedabad
  • Event organised as part of JP Morgan Healthcare Trip
  • Discussions limited to publicly available information
powered bylight_fuzz_icon
51169391

*this image is generated using AI for illustrative purposes only.

Concord Biotech will host a group meeting with analysts and institutional investors on September 23, 2026. The session is scheduled for 12:30 pm in Ahmedabad as part of the JP Morgan Healthcare Trip.

Meeting Details

The company confirmed the schedule in a disclosure filed with the National Stock Exchange of India Limited and BSE Limited on September 17, 2026. The interaction aims to provide updates based on publicly available information.

Date Time Organised By Nature of Meeting Place
September 23, 2026 12:30 pm JP Morgan Healthcare Trip Group Meeting Ahmedabad

Regulatory Disclosure

The announcement was made pursuant to Regulation 30(6) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015. Paritosh Trivedi, Company Secretary and Compliance Officer, signed the intimation.

The company stated that no unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. Changes to the schedule may occur due to exigencies on the part of the host or the company.

Historical Stock Returns for Concord Biotech

1 Day5 Days1 Month6 Months1 Year5 Years
+1.34%+0.60%+1.52%+27.22%-9.12%+56.27%

How might analyst sentiment from the JP Morgan Healthcare Trip influence Concord Biotech's stock valuation in the immediate quarter?

What specific pipeline milestones or commercial updates are investors likely to prioritize during this group interaction?

Could the focus on publicly available information limit the meeting's impact on short-term trading volumes compared to earnings calls?

Concord Biotech to host investor meet on August 26 in Ahmedabad

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Concord Biotech will host an investor meet on August 26, 2026
  • The group meeting is organized by Phillip Capital PCG in Ahmedabad
  • Sessions will run from 1:00 pm to 3:00 pm IST
  • Only publicly available information will be discussed
  • No unpublished price-sensitive information will be shared
powered bylight_fuzz_icon
48833674

*this image is generated using AI for illustrative purposes only.

Concord Biotech Limited will host a group meeting for analysts and institutional investors on August 26, 2026, in Ahmedabad.

The interaction is scheduled from 1:00 pm to 3:00 pm and will be organized by Phillip Capital PCG. Company officials will participate in the session to address queries from market participants.

Meeting Details

Parameter Details
Date August 26, 2026
Time 1:00 pm to 3:00 pm
Organizer Phillip Capital PCG
Location Ahmedabad
Format Group Meeting

The company disclosed that discussions will be strictly based on publicly available information. No unpublished price-sensitive information (UPSI) is intended to be shared during the interactions.

This intimation was issued pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations 2015. The notice was signed by Paritosh Trivedi, Company Secretary & Compliance Officer, on August 21, 2026.

The company noted that changes to the schedule may occur due to exigencies on the part of participants or the company.

Historical Stock Returns for Concord Biotech

1 Day5 Days1 Month6 Months1 Year5 Years
+1.34%+0.60%+1.52%+27.22%-9.12%+56.27%

How might analyst sentiment following this meeting influence Concord Biotech's stock valuation in the subsequent quarter?

What specific operational or financial metrics are investors likely to scrutinize during the August 26 interaction?

Could the insights shared by company officials signal any strategic shifts in Concord Biotech's R&D pipeline or market expansion plans?

More News on Concord Biotech

1 Year Returns:-9.12%